Rankings
▼
Calendar
VRCA Q3 2019 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
VRCA
Verrica Pharmaceuticals Inc.
$59M
Q3 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7M
Net Income
-$6M
EPS (Diluted)
$-2.45
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$8M
Stock-Based Comp.
$905,000
Balance Sheet
Total Assets
$76M
Total Liabilities
$4M
Stockholders' Equity
$72M
Cash & Equivalents
$11M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$7M
-$7M
+8.7%
Net Income
-$6M
-$7M
+9.6%
← FY 2019
All Quarters
Q4 2019 →